Treatment Delay in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary

Jinghao Sun1, Yixin Ma1, Hui Chen2

  • 1Department of Geriatrics, Xuanwu Hospital, Capital Medical University, National Clinical Research Center for Geriatric Diseases, Beijing, China.

JACC. Asia
|May 2, 2026
PubMed

Insights

Prehospital delay significantly impacts ST-segment elevation myocardial infarction (STEMI) treatment outcomes in Beijing. Strategies should enhance hospital readiness, promote ambulance use, and reduce disparities to improve STEMI care.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • Primary percutaneous coronary intervention (PPCI) is the gold standard for ST-segment elevation myocardial infarction (STEMI).
  • Timely treatment is critical for improving STEMI patient prognosis.
  • Treatment delays remain a significant challenge in STEMI management.

Purpose of the Study:

  • To investigate the extent of treatment delays in STEMI patients undergoing PPCI in Beijing.
  • To identify key factors influencing treatment delays, including time of admission, mode of transport, and hospital level.

Main Methods:

  • A retrospective analysis of 13,445 STEMI patients who underwent PPCI across 65 hospitals in Beijing (2018-2022).
  • Data on total ischemic time (TIT), symptom onset-to-door time (S2D), and door-to-balloon time (D2B) were collected.
  • Mixed-effects models were used to analyze the impact of admission timing, transport mode, and hospital type on treatment delays.

Main Results:

  • Median TIT, S2D, and D2B were 188, 116, and 72 minutes, respectively.
  • Off-hours admissions had longer S2D but shorter D2B compared to on-hours admissions.
  • Ambulance transport was associated with significantly shorter S2D and D2B compared to self-transport.
  • Tertiary hospitals showed longer S2D than non-tertiary hospitals.

Conclusions:

  • Prehospital delay (S2D) constitutes the largest portion of TIT in Beijing STEMI patients.
  • Improving hospital preparedness and increasing ambulance utilization are crucial for reducing STEMI treatment delays.
  • Addressing interhospital disparities in care is essential for optimizing STEMI management.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
943